Amneal Pharmaceuticals to Develop Omalizumab Biosimilar for Allergy Treatments

MT NewswiresJul 1 21:49

Goldman Sachs Sticks to Their Buy Rating for Novartis AG (NOVN)

TipRanksJul 1 17:25

FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen

Yahoo FinanceJun 27 00:56

Exsilio Therapeutics Launches With $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases

PR NewswireJun 25 17:00

Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors

BusinesswireJun 25 04:05

Nestle Carefully Targets Weight-Loss Drug Users With New Food Line

BenzingaJun 21 18:18